Science For Sale - Interactions between academia and businesses could affect the future of scientific research by Roberts, John D.
70WWW.CEN-ONLINE.ORG MARCH 24, 2008
DANIEL GREENBERG is a well-known 
investigative reporter of science, and his 
current book deals with bitter and divisive 
controversies over the role of research 
universities in societal and commercial 
arenas. His modus recalls insistent ad-
vice given by the Watergate source Deep 
Throat to Washington Post reporters Bob 
Woodward and Carl Bernstein: “Follow the 
money!”
The money theme is strongly coupled to 
“relevance,” where relevance as used here 
refers to an important factor in the award-
ing of funds for scientific or engineering re-
search. The problem with relevance is that 
it raises the question, relevant to whom? 
For example, evidence that global climate 
change is connected with human activity 
is relevant to many 
people. Evidence 
to the contrary is 
relevant to others. 
When society finally 
pushes to do more 
than hand-wringing 
about global climate 
change, billions, per-
haps in the long run 
trillions, of dollars 
can be made from 
either outcome.
Needless to say, with financial stakes 
so high for and against global-climate-
change research, money is widely used by 
dueling participants as a weapon. It’s used 
to advertise, lobby, influence vocal syco-
phants to preach, and try to draw on highly 
respected research universities to provide 
plausible expertise to influence the fray’s 
outcome in one way or the other. So “fol-
low the money” becomes quite relevant in 
awarding large grants to universities for 
climate-change research.
Greenberg’s book, which is organized 
into three parts, starts with this sentence 
in the Introduction, “In all cases, money 
drives the engine of a university.” In part 
1, he is more specific: “On money matters, 
all of these [research] universities are 
puzzling and contradictory organizations. 
Virtually all describe themselves as hard-
pressed financially, even as they ingest 
colossal sums from a variety of sources, ac-
cumulate huge endowments, and operate 
on enormous budgets.” One can argue that 
“colossal,” “huge,” and “enormous” may 
apply to just a few research universities, 
but one cannot dismiss them altogether.
UNIVERSITY-INDUSTRY joint research 
projects are special Greenberg targets 
because of potential conflicts of interest 
between traditional university values and 
commercial interests. As an example, the 
author tells us, “In 2002 Stanford Univer-
sity launched a Global Climate and Energy 
Project, priced at $225 million over 10 
years. ExxonMobil, a declared disbeliever 
in global climate 
change and gener-
ous angel for right-
wing think tanks, 
was chief sponsor 
and donor of up 
to $100 million 
for the project.” 
Other contributors 
were General Elec-
tric, Toyota, and 
Schlumberger, all 
of which had some 
interest in the outcome, but not necessarily 
in the same way as ExxonMobil, which elic-
ited a comment at the time that the petro-
leum company was trying to “greenwash its 
environmental reputation” for a sum about 
equivalent “to its paper-clip budget.”
Of course, Stanford offered assurances 
“that their project would respect tradi-
tional scientific and academic values,” and 
indeed, if there have been difficulties in 
the ensuing six years, they are not reported 
by the author. Still, constitutionally suspi-
cious readers will worry that the amount of 
money involved could lead to trouble when 
an extension is negotiated if ExxonMobil 
should become displeased with the project 
achievements. A similar arrangement for
climate-change research was reported by 
C&EN in 2007 between the University of 
California, Berkeley, and British Petroleum 
for $500 million, which seems to mandate 
that a contingent of BP personnel be sta-
tioned on campus. A further Berkeley-Dow 
research agreement was more recently 
reported in C&EN. Both agreements have 
received considerable criticism from 
Berkeley faculty and others as being inap-
propriate to the university’s basic educa-
tional mission.
It should not be assumed that such uni-
versity-industry arrangements are sudden-
ly new or unique. In California Institute of 
Technology’s early days (1925–35), a build-
ing was built and important research was 
done for Southern California Edison Co.
through a collaboration of Caltech’s elec-
trical engineers and Edison on high-voltage 
power transmission lines. Starting in 1926, 
through the Guggenheim Aeronautical 
Laboratory led by famed aerodynamicist 
Theodore von Kármán, Caltech worked 
with aircraft companies using an industry-
funded wind tunnel on campus, with great 
benefit to the participants. In the 1930s, 
Caltech physicists collaborated with the 
medical profession on the use of high-en-
ergy radiation to treat cancers.
Around 1980, Caltech’s Carver Mead 
created an industry consortium with lead-
ing electronics companies to research 
architectures for large-scale arrays of inte-
grated silicon transistors. This project had 
a difficult gestation associated with intel-
lectual property rights until Mead got the 
participating companies to finesse the is-
sue. Unlike with other such collaborations, 
Mead decided when enough was enough 
and moved on to other things. If ethical 
concerns were voiced at that time or later 
about these projects at Caltech, they were 
minor enough, or so far in the past, as to 
not be reported by Greenberg.
Greenberg gives excellent attention to 
the Bayh-Dole Act of 1980. Bayh-Dole came 
about because of legal ambiguity concern-
ing the ownership of patents created in 
universities using federal research sup-
port from agencies with their own policies 
respecting patent ownership. To solve this 
BOOKS
THE PERILS, 
REWARDS, AND 
DELUSIONS 
OF CAMPUS 
CAPITALISM,
by Daniel S. 
Greenberg,
University of 
Chicago Press, 
2007, 311 pages, $25 
hardcover (ISBN 
978-0-226-30625-4)
SCIENCE FOR SALE
Interactions between ACADEMIA AND BUSINESSES
could affect the future of scientific research
REVIEWED BY JOHN D. ROBERTS
“In all cases, money drives 
the engine of a university.”
71WWW.CEN-ONLINE.ORG MARCH 24, 2008
S
H
U
T
T
E
R
S
T
O
C
K
problem, Bayh-Dole was passed and is still 
in effect.
Many readers may be unaware of the 
specifics of this almost 30-year-old act, so 
what is involved? The author starts with an 
excerpt from the act: “It is the policy and 
objective of the Congress to use the patent 
system to promote the utilization of in-
ventions arising from federally supported 
research or development ... [and] ... to 
promote collaboration between commer-
cial concerns and nonprofit organizations, 
including universities.”
Greenberg then says: “At that pace of 
growth and financial level … [billions per 
year] ... science spending became conspic-
uous and politically interesting. Scientific 
inquiry as a manifestation of the human 
spirit is an inspiring notion, but politicians 
wanted tangible results, not just arcane 
research papers.”
THE ACT GIVES universities ownership of 
patents generated by federal support but 
allows the government royalty-free rights 
to use of the patents. At the same time, 
the scientist(s) whose work created the 
patents could arrange with their universi-
ties to start spin-off companies and enrich 
themselves, if successful, by either selling 
out to a larger company or, in the style of 
Microsoft and Google, growing their com-
panies to extreme value.
Bayh-Dole mandates that patents gener-
ated with government support be offered 
to commercial interests. Just how strongly 
this and other provisions of the act are 
enforced is uncertain, but it is clear that, 
if unheeded, serious legal complications 
could result. One outcome has been the 
growth of technology-transfer offices in 
almost every university with a research 
program in science and/or engineering.
Greenberg is vitriolic over the Associa-
tion of University Technology Managers 
(AUTM) for overblowing the success of 
technology transfer as mandated by the 
Bayh-Dole Act. Greenberg says sarcasti-
cally, “In AUTM’s version of the story, the 
Bayh-Dole Act is an unalloyed success, 
undeserving of the reservations and criti-
cisms by theory-blinkered economists and 
antediluvian purists … nostalgically on a 
long-ago gentlemanly era of science.”
Whether or not such sarcasm is warrant-
ed, it is a fact that relatively few technol-
ogy-transfer offices produce large returns, 
and the patent, legal, and other expenses 
of these offices can minimize or outweigh 
returns. Although early on AUTM empha-
sized the financial gains to be achieved in 
technology transfer, it and the universities 
are now converted to extolling the broad 
societal gains rather than desired financial 
outcomes. Nonetheless, the author reports 
in detail on Washington University in St. 
Louis and Georgia Institute of Technol-
ogy as prime examples of institutions that 
have thoroughly embraced the new reality 
of tech transfers and that profit financially 
from them.
As for “follow the money,” Greenberg 
describes situations where ethical con-
cerns, conflicts of interest, legal battles, 
unauthorized or authorized advertising 
statements implying university endorse-
ment for particular uses of licensed pat-
ents, and the like have tarnished great 
institutions or affected involved faculty. 
Several cases detailed by the author will be 
found by the interested reader to include 
such examples as Novartis/Syngenta with 
Berkeley, Johns Hopkins University and 
a skin care product, and large consulting 
contracts for senior NIH personnel with 
pharmaceutical companies.
PART 2 of Greenberg’s book takes a differ-
ent tack in which 70 pages of interesting 
material, well worth reading, have been 
gleaned from six veterans of the tech-
nology-transfer revolution. Most of the 
interviews are two or more years old, and 
minds may not be the same today. Included 
are bitter remarks by chemistry professor 
Robert Holton of Florida State University 
on dealing with pharmaceutical companies 
with regard to Taxol; a different experi-
ence with professor Robert M. Dickson of 
Georgia Tech on imaging techniques, with 
a surprise ending to an open conversation; 
professor William S. Wold with conflict 
of interest in biomedical research at Saint 
Louis University; Timothy Mulcahy, then 
of the University of Wisconsin, Madison, 
on internal university relations associated 
with tech-transfer activities; and a conver-
sation with Drummond Rennie, who has 
been connected with the New England Jour-
nal of Medicine and the Journal of the Ameri-
can Medical Association, with deep concerns 
for possible bias in reporting on tests of 
the efficacies of drugs, where the authors 
represent institutions or others who have 
financial interests in those tests.
The final part of the book consists of two 
essays: “What’s Right and Wrong, and How 
To Make It Better” and a tasteless parable 
of the exploits of “Grant Swinger.” The first 
essay confronts scientific fraud, which em-
barrasses the scientific community even 
though—considering the yearly volume 
of published papers—high-profile cases, 
mostly driven by failures to reproduce im-
portant experimental results, are relatively 
few. The level to which small fudges occur 
in published data can hardly be expected to 
be known. However, this essay deals mainly 
with “wrongs,” which range over topics 
already discussed or alluded to. Substantial 
criticism is also directed toward the unwill-
ingness of the University of Pennsylvania 
to reveal its financial agreements with in-
dustrial sponsors, which makes it difficult 
to “follow the money.”
Justification for such practices is easily 
constructed, but is this the proper stance 
for either public or private universities to 
take? It is now mandatory for many jour-
nals to include footnotes with information 
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about conflicts of interest with regard to 
the subject matter of submitted papers, but 
Greenberg notes a trend to ignore regula-
tions about conflicts of interest. He reports 
that in a study of 3,200 scientists, many 
said they had changed details of their pa-
pers as a result of persuasion from a fund-
ing source.
Among corrective measures for conflicts 
of interest, one procedure adaptable from 
information technology is “open source” 
collaborations through which intellectual 
property will be free for academic and com-
mercial uses. In such arrangements, the 
universities do not own patents and avoid 
many problems. To extend open source to 
pharmaceutical research is a different mat-
ter, but Greenberg suggests that changes in 
the patent system itself could have many 
advantages. Other measures could include 
the aforementioned need for transpar-
ency of agreements between industry and 
universities, tightened internal scrutiny by 
universities of their own research opera-
tions, and continued efforts of journal edi-
tors to stem the tide of deceit in research 
publications.
This reviewer was disappointed with 
part 1, which was highly critical of the 
compensation of university presidents, 
even though their levels of compensation 
are hardly commensurate with upper-level 
industrial management. One should expect 
that university presidents are likely to 
have more workhours and a greater variety 
of responsibilities than company CEOs. 
Universities and their biology departments 
are also strongly criticized for not being 
able to provide tenure-track positions until 
postdoctoral fellows reach their late 30s or 
early 40s. But the author fails to recognize 
that biology and other sciences are victims 
of their own success. Success here means 
wonderful science to work on and capable 
postdoctoral fellows, but they are too many 
to be easily assimilated by the number and 
sizes of existing academic departments and 
facilities. Yet in other places in the book, 
the author sharply criticizes universities 
for pushing to keep expanding.
The book is clearly an interesting read, 
even if it may raise temperatures under the 
collars of many company personnel and 
the faculty and university administrators 
with high stakes in technology transfers.
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